UCLA's Harley Liker, M.D., M.B.A., Joins Vela Pharmaceuticals Scientific Advisory Board.Business Editors/Health/Medical Writers LAWRENCEVILLE, N.J.--(BUSINESS WIRE)--May 27, 2003 Vela vela plural of velum. Pharmaceuticals Inc. (VelaPharm), a privately held company privately held company A firm whose shares are held within a relatively small circle of owners and are not traded publicly. specializing in the "rediscovery" and development of medicines to treat diseases related to the central nervous system (CNS See Continuous net settlement. CNS See continuous net settlement (CNS). ), announced today the addition of Harley Liker, M.D., M.B.A., to its Scientific Advisory Board. Chosen by Los Angeles Magazine as one of the best doctors in Los Angeles and by Town & Country as one of the top doctors in the U.S., Dr Liker is the primary care provider to more than fifty of southern California's leading physicians. Dr. Liker received his medical degree with honors from the Albert Einstein College of Medicine
The Albert Einstein College of Medicine (AECOM) is a graduate school of Yeshiva University. It is a private medical school located in the Jack and Pearl Resnick Campus of Yeshiva University in the Morris Park (New York) in 1992. He completed his internship and residency in Internal Medicine at the UCLA Medical Center UCLA Medical Center is a hospital located on the campus of the University of California, Los Angeles in Los Angeles, California. It is rated as one of the top three hospitals in the United States and is the top hospital on the West Coast according to US News & World Report. . Afterwards, he joined the faculty of the David Geffen School of Medicine at UCLA UCLA School of Medicine or David Geffen School of Medicine at UCLA is an accredited allopathic medical school located in Los Angeles, California, United States. The school was named in honor of media mogul David Geffen who donated $200 million in unrestricted funds to the , where he is Assistant Clinical Professor of Medicine and has trained over 100 medical students and residents. Dr. Liker has lectured on a broad range of topics, including cancer prevention, healthcare maintenance, Gastrointestinal (GI) Diseases, Heart Disease and Diabetes. He serves on a global advisory board for AstraZeneca Pharmaceuticals and regularly consults for large pharmaceutical corporations. Dr. Liker also serves on the board of directors of the Venice Family Clinic, the largest free clinic in the United States. "Dr. Liker is a leader at UCLA, a practicing internist, and an expert in such areas as GI disorders, women's health, and the treatment of psychiatric disorders in primary care," said Kevin L. Keim, MSc, PhD, President, & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of VelaPharm. "His diverse skill set and broad knowledge base will help us as we expand our vision of CNS-related illnesses and their treatments beyond the traditional realms of psychiatry and neurology." VelaPharm Scientific Advisory Board VelaPharm's Scientific Advisory Board is composed of eminent scientists with recognized expertise in drug development, clinical trials, patient care, and scientific discovery. Members of the advisory board advise VelaPharm on the in-licensing, rediscovery and development of CNS-related molecular assets. Current members are: (Chairman) Martin B. Keller, M.D., Brown University Department of Psychiatry; Donald F. Klein, M.D., Columbia University College Of Physicians and Surgeons The Columbia University College of Physicians and Surgeons, abbreviated P&S, is a graduate school of Columbia University located on the health sciences campus in the Washington Heights neighborhood of Manhattan. ; Ranga Krishnan, M.D., Duke University Medical Center; Seth Lederman, M.D., Columbia University College of Physicians and Surgeons, Harley Liker, M.D., M.B.A., David Geffen School of Medicine at UCLA, Stuart A. Montgomery, M.D., Imperial College School of Medicine The Imperial College School of Medicine is the medical school of Imperial College London in England. The Faculty of Medicine was established in 1997, bringing together all the major West London medical schools into one world-class institution (see infra). . About VelaPharm Vela Pharmaceuticals Inc. (www.velapharm.com), a privately held company, specializes in the "rediscovery" and development of medicines to treat diseases related to the central nervous system (CNS). The company uses its extensive CNS drug development expertise to leverage the value of "known" molecular assets. Investors include JP Morgan Partners, New Enterprise Associates, and Venrock. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion